Supplement monograph

SAMe

A mood and joint-positioned compound where antidepressant context, bipolar-risk screening, GI tolerance, and claim separation matter more than methylation marketing.

Practical read

Review mood history and medication context before any timing question. If a clinician supports use, keep dose, timing, and other mood-active products stable so effects and adverse signals are interpretable.

Decision frame

SAMe: what to check before it earns a slot

Timing rule

Review mood history and medication context before any timing question. If a clinician supports use, keep dose, timing, and other mood-active products stable so effects and adverse signals are interpretable.

Form lens

Enteric-coated tablets: common stability-focused formatMood blends: harder to attribute effectsJoint blends: often mix several claims

Safety lens

Antidepressants and other serotonergic medicines require clinician reviewBipolar disorder or mania history is a high-caution contextGI effects, anxiety, or insomnia can limit use

Best fit

  • Mood-stack safety audits
  • Joint-stack claim review
  • Serotonergic-overlap screening

Form notes

  • Enteric-coated tablets: common stability-focused format
  • Mood blends: harder to attribute effects
  • Joint blends: often mix several claims

Watchouts

  • Antidepressants and other serotonergic medicines require clinician review
  • Bipolar disorder or mania history is a high-caution context
  • GI effects, anxiety, or insomnia can limit use

Evidence Brief

Get supplement timing and safety notes as they ship.

Monthly evidence briefs. No hype, no disease claims, no influencer supplement stacks.

These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Generated by AI. Always verify with a healthcare professional. Educational information only. Not a substitute for professional medical advice.